Spinach vs Google DeepMind
Side-by-side trajectory, velocity, and editorial themes.
Filling out the meeting-transcript-to-AI-agent integration matrix, one connector at a time.
Spinach is publishing a tightly coordinated content matrix: how to pipe Zoom, Google Meet, and Microsoft Teams transcripts into every major AI workspace and dev tool. Two date clusters dominate — five posts on April 24 and five more on May 1 — each running the same template across a different combination of source meeting platform and destination agent (Claude Code, Claude Cowork, Codex, Glean, Notion AI, HubSpot, Linear).
Spinach is repositioning from "AI meeting assistant" to "transcript pipeline for the rest of your AI stack," with its MCP server as the underlying connective tissue. The choice of destinations is telling — heavy emphasis on engineering tooling (Claude Code, Codex, Linear) suggests the GTM is moving toward technical buyers rather than the original ops/PM audience.
Expect more matrix entries — Cursor, Devin, JetBrains AI, ChatGPT desktop, Salesforce — published in fast batches. A consolidated "integrations directory" or marketplace page is the natural next visible artifact.
DeepMind is repositioning Gemini as the substrate for scientific research, not just consumer AI.
DeepMind's recent output is dominated by Co-Scientist case studies and the formal launch of a 'Gemini for Science' suite, with applied research wins clustered around biology — aging, ALS, liver disease, infectious disease triggers. A second strand expands consumer-facing tools (Project Genie + Street View) for Google AI Ultra subscribers and pushes on content provenance. National partnership announcements (Singapore) round out the geopolitical surface.
The center of gravity is shifting from frontier model releases to vertical applications, particularly in life sciences. Co-Scientist appears to be moving from internal project to a packaged offering institutions can collaborate on. Consumer features and content authenticity work continue in parallel but feel secondary to the science push.
Expect a formal Co-Scientist productization announcement with institutional access tiers within the next quarter, and additional 'Gemini for X' verticals (likely materials science or drug discovery) to follow the science framing.
See more alternatives to Spinach →
See more alternatives to Google DeepMind →